Cheryl Jernigan, C.P.A., F.A.C.H.E., is an 18-year breast cancer “thriver” and breast health advocate. She is Chair of the Breast Cancer Prevention Center Advocate Advisory Board for The University of Kansas Medical Center and The University of Kansas Hospital. Ms. Jernigan is also a founding and current board member and Chair of the Strategic Mission Committee of the Greater Kansas City Affiliate of Susan G. Komen, and a member of the steering committee of Komen’s Advocates In Science program.
An active research advocate, Ms. Jernigan is a member of the National Cancer Institute’s Central Institutional Review Board for Adult Late Phase Clinical Trials; the Clinical Trials Transformation Initiative’s Patient Leadership Council; and the Multi-Regional Clinical Trials Center’s Working Group on Returning Clinical Trial Results to Participants. She is the Lead Advocate for the Greater Plains Clinical Data Research Network (a Patient-Centered Outcomes Research Initiative (PCORI) grant); a past member of the National Cancer Institute’s Director’s Consumer Liaison Group (DCLG); and has served as an advocate reviewer for Komen’s Research Program, the U.S. Congressionally Directed Breast Cancer Research Program, and the Lance Armstrong Foundation.